Showing results (291-300 of 676) with videos related to
Sort By:
Pageof 68
Clinical Advances in Hematology & Oncology : H&O|February 7, 2015
Platinum agents in the treatment of early-stage triple-negative breast cancer: is it time to change practice?Laila Saied Agrawal, Ingrid A MayerClinical Advances in Hematology & Oncology : H&O|July 2, 2020
The role of PARP inhibitors in germline BRCA-associated pancreatic ductal adenocarcinomaGordon T Moffat, Eileen M O'ReillyClinical Advances in Hematology & Oncology : H&O|June 9, 2020
Perioperative approaches to kidney cancerKennedy Iheanacho, Ulka VaishampayanClinical Advances in Hematology & Oncology : H&O|August 19, 2021
New targets in endocrine-resistant hormone receptor-positive breast cancerLaura C Kennedy, Ingrid A MayerClinical Advances in Hematology & Oncology : H&O|November 14, 2025
Unlocking the potential of patient-reported outcomes: practical uses in routine oncology careRoshan Paudel, Nadine J McCleary, Michael J Hassett, et al.Clinical Advances in Hematology & Oncology : H&O|December 29, 2025
What cancer patients may or may not be surprised to know about survivorshipJohn W Ragsdale, Kevin C Oeffinger, Celeste A RousseauClinical Advances in Hematology & Oncology : H&O|July 1, 2025
The promise of molecular residual disease (MRD) testing for patients with colorectal cancerTanios S Bekaii-Saab, Robert E SchoenClinical Advances in Hematology & Oncology : H&O|September 22, 2025
Integration of immunotherapy into the frontline treatment of acute lymphoblastic leukemiaAjoy Dias, Mark R LitzowClinical Advances in Hematology & Oncology : H&O|July 29, 2025
First-line use of antiangiogenic agents in unresectable hepatocellular carcinoma: a double-edged sword?Aditya Mahadevan, Armon Azizi, Nadine Abi-Jaoudeh, et al.Clinical Advances in Hematology & Oncology : H&O|July 29, 2025
Revolutionizing breast cancer treatment: the promise of antibody-drug conjugatesSamer Alkassis, John A Glaspy, Aditya BardiaPageof 68